-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
September 01, 2013 - 1
Comparative Effectiveness Review
Number 125
Testing of CYP2C19 Variants and Platelet
Reactivity for Guiding Antiplatelet Treatment
Executive Summary
Background
Burden of Disease and Clinical
Setting
Approximately 82 million Americans
currently suffer from some form of
cardiovascular disease.1 In the United …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
January 01, 2025 - Table C-1. KQ 3,4, 5 Char.
Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (years) Eligible Minimum Age Actual Minimum Age …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
January 01, 2025 - Table C-1. KQ 3,4, 5 Char.
Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5
First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (Years) Eligible Minimum Age Actual Minimum Age …